The Cancer Risk Evaluation Program (CREP)
The Joan Karnell Cancer Center at Pennsylvania
Hospital offers the Cancer
Risk Evaluation Program (CREP) for people
concerned about their risk for cancer. This program,
offered in collaboration with the Abramson
Cancer Center of the University of Pennsylvania,
offers information, evaluation and follow up
for those concerned about a personal or genetic
risk for cancer. The program primarily addresses
the risk for breast, ovarian and gastrointestinal
cancers, but is also available for other
types of cancer and cancer syndromes.
A multidisciplinary team reviews a woman’s personal and family
history, discusses the risk factors involved in hereditary cancer,
determines if genetic testing would be appropriate, and outlines a
plan for continued monitoring for early detection and personal risk
reduction.
Learning more about individualized risks for developing cancer may
help patients and their doctors make informed decisions about health
care. Individuals with any of the following in their family history
may benefit from this program:
- A cancer diagnosis at an early age, particularly
breast, colon or ovarian cancers diagnosed
under the age of 50.
- Multiple generations of relatives affected with the same or related
cancers.
- Family members with more than one type of cancer.
- Bilateral breast cancer (on both sides or in both breasts).
- Family members diagnosed with cancer at an age considered early
for that particular cancer.
- Family members with more than one type of cancer, such as a woman
with both breast and ovarian cancer.
- Rare or unusual cancers.
For more information, contact Jill Siegfried, MS, Program Coordinator
and Genetic Counselor, at the Joan Karnell Cancer
Center, at 215-829-6528.
Learning more about individualized risks for developing cancer may
help patients and their doctors make informed decisions about health
care.
|
